Related references
Note: Only part of the references are listed.Influenza: annual seasonal severity
Patrick Gavigan et al.
CURRENT OPINION IN PEDIATRICS (2019)
Community-acquired bacterial co-infection predicts severity and mortality in influenza-associated pneumonia admitted patients
Fei Teng et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2019)
The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09
Chandini Raina MacIntyre et al.
BMC INFECTIOUS DISEASES (2018)
Anti-inflammatory effects of adjunctive macrolide treatment in adults hospitalized with influenza: A randomized controlled trial
Nelson Lee et al.
ANTIVIRAL RESEARCH (2017)
Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection An Open-label Randomized, Controlled, Phase IIb/III Trial
Ivan F. N. Hung et al.
CHEST (2017)
Current Approaches for Diagnosis of Influenza Virus Infections in Humans
Sai Vikram Vemula et al.
VIRUSES-BASEL (2016)
A Critical, Nonlinear Threshold Dictates Bacterial Invasion and Initial Kinetics During Influenza
Amber M. Smith et al.
SCIENTIFIC REPORTS (2016)
Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of Disease
Agnieszka Rynda-Apple et al.
INFECTION AND IMMUNITY (2015)
Adjuvant Immunosuppression in the Management of Severe Influenza: Friend or Foe?
Michael G. Ison
CRITICAL CARE MEDICINE (2014)
Antiviral combinations for severe influenza
Jake Dunning et al.
LANCET INFECTIOUS DISEASES (2014)
Efficacy of Combination Therapy with Oseltamivir Phosphate and Azithromycin for Influenza: A Multicenter, Open-Label, Randomized Study
Hiroshi Kakeya et al.
PLOS ONE (2014)
Influenza antiviral resistance in the Asia-Pacific region during 2011
Sook-Kwan Leang et al.
ANTIVIRAL RESEARCH (2013)
Adjunctive therapies and immunomodulatory agents in the management of severe influenza
David S. Hui et al.
ANTIVIRAL RESEARCH (2013)
Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia
I. Martin-Loeches et al.
INTENSIVE CARE MEDICINE (2013)
Bacterial Coinfection in Influenza A Grand Rounds Review
Daniel S. Chertow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09
A. Bradley-Stewart et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Depletion of Alveolar Macrophages during Influenza Infection Facilitates Bacterial Superinfections
Hazem E. Ghoneim et al.
JOURNAL OF IMMUNOLOGY (2013)
Immune Dysfunction and Bacterial Coinfections following Influenza
Dennis W. Metzger et al.
JOURNAL OF IMMUNOLOGY (2013)
Kinetics of Coinfection with Influenza A Virus and Streptococcus pneumoniae
Amber M. Smith et al.
PLOS PATHOGENS (2013)
Viral Infection in Patients with Severe Pneumonia Requiring Intensive Care Unit Admission
Sang-Ho Choi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Macrolide Antibiotics and Survival in Patients With Acute Lung Injury
Allan J. Walkey et al.
CHEST (2012)
A Population-Based Study of Neurologic Manifestations of Severe Influenza A(H1N1)pdm09 in California
Carol A. Glaser et al.
CLINICAL INFECTIOUS DISEASES (2012)
Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States
Todd W. Rice et al.
CRITICAL CARE MEDICINE (2012)
Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza
Mark L. Metersky et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2012)
Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia
Nelson Lee et al.
ANTIVIRAL THERAPY (2011)
Community-Acquired Respiratory Coinfection in Critically III Patients With Pandemic 2009 Influenza A(H1N1) Virus
Ignacio Martin-Loeches et al.
CHEST (2011)
Cytokine Response Patterns in Severe Pandemic 2009 H1N1 and Seasonal Influenza among Hospitalized Adults
Nelson Lee et al.
PLOS ONE (2011)
Fitness of neuraminidase inhibitor-resistant influenza A viruses
Tatiana Baranovich et al.
CURRENT OPINION IN VIROLOGY (2011)
Influenza Virus Infection Decreases Tracheal Mucociliary Velocity and Clearance of Streptococcus pneumoniae
Lynnelle A. Pittet et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Delayed Clearance of Viral Load and Marked Cytokine Activation in Severe Cases of Pandemic H1N1 2009 Influenza Virus Infection
Kelvin K. W. To et al.
CLINICAL INFECTIOUS DISEASES (2010)
Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada
Anand Kumar et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Treatment with Protein Synthesis Inhibitors Improves Outcomes of Secondary Bacterial Pneumonia after Influenza
Asa Karlstrom et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review
Charlotte Warren-Gash et al.
LANCET INFECTIOUS DISEASES (2009)
Pneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in Mexico
Rogelio Perez-Padilla et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand.
Steven A. R. Webb et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain
Jordi Rello et al.
CRITICAL CARE (2009)
Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza
Jesus F. Bermejo-Martin et al.
CRITICAL CARE (2009)
Complications of viral influenza
Michael B. Rothberg et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Macrolides as immunomodulatory medications for the therapy of chronic lung diseases
Yolanda S. Lopez-Boado et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Hypercytokinemia and Hyperactivation of Phospho-p38 Mitogen-Activated Protein Kinase in Severe Human Influenza A Virus Infection
N. Lee et al.
CLINICAL INFECTIOUS DISEASES (2007)
Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza a virus infection
N. Lee et al.
CLINICAL INFECTIOUS DISEASES (2007)
Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection
Lynnelle A. McNamee et al.
INFECTION AND IMMUNITY (2006)
Influenza-associated hospitalizations in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice
M Seki et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Respiratory viruses predisposing to bacterial infections: role of neuraminidase
VT Peltola et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection
KF van der Sluijs et al.
JOURNAL OF IMMUNOLOGY (2004)
Lethal Synergism between influenza virus and Streptococcus pneumoniae:: Characterization of a mouse model and the role of platelet-activating factor receptor
JA McCullers et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
The 1918 Spanish influenza: integrating history and biology
AH Reid et al.
MICROBES AND INFECTION (2001)
Share Paper
